Skip to main content
. 2019 Aug 20;10:1874. doi: 10.3389/fmicb.2019.01874

FIGURE 7.

FIGURE 7

(A) Secretion of exopolysaccharide (EPS) in Xoo wild-type and that of treatment with I-9, I-12, or I-13 compounds had no significant difference. From left to right, it provided WT, WT + DMSO, WT + I-9, WT + I-12, and WT + I-13. Error bars represent standard deviation from three repeats. (B) Detection of cellulase secreted by Xoo grown in PSA containing 0.5% carboxymethyl cellulose for 24 h. Pale-yellow clear zones showed no difference between Xoo wild-type and that of treatment with I-9, I-12, or I-13 compounds. (C) Detection of xylanase secreted by Xoo grown in PSA 0.2% RBB-xylan for 48 h. Both Xoo wild-type and that of treatment with I-9, I-12, or I-13 compounds were appeared as the white clear zones among a blue background. (D) Detection of swimming motility on 0.3% soft agar plates supplemented with I-9, I-12, or I-13 compounds at 28°C after 72 h.